Endpoints and Outcomes After Immunotherapy for Food Allergy: What Is Meaningful for Patients?
- 1 February 2023
- journal article
- review article
- Published by Elsevier in The Journal of Allergy and Clinical Immunology: In Practice
- Vol. 11 (4) , 998-1007
Abstract
No abstract availableKeywords
Funding Information
- National Health and Medical Research Council
- Pfizer
- Novartis
- European Cooperation in Science and Technology
This publication has 64 references indexed in Scilit:
- Patient engagement in research: a systematic reviewBMC Health Services Research, 2014
- Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapyJournal of Allergy and Clinical Immunology, 2014
- Content and Quality of 10 000 Controlled Trials in Schizophrenia Over 60 YearsSchizophrenia Bulletin, 2012
- Outcome selection and role of patient reported outcomes in contemporary cardiovascular trials: systematic reviewBMJ, 2010
- Definition, reporting, and interpretation of composite outcomes in clinical trials: systematic reviewBMJ, 2010
- Summary of the 2008 National Institute of Allergy and Infectious Diseases–US Food and Drug Administration Workshop on Food Allergy Clinical Trial DesignJournal of Allergy and Clinical Immunology, 2009
- A Systematic Review of Studies That Aim to Determine Which Outcomes to Measure in Clinical Trials in ChildrenPLOS Medicine, 2008
- The end of the disease eraThe American Journal of Medicine, 2004
- Measuring inconsistency in meta-analysesBMJ, 2003
- The importance of patient preferences in treatment decisions—challenges for doctorsBMJ, 2003